Showing results (31-40 of 499) with videos related to
Sort By:
Pageof 50
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|December 27, 2012
[Expression, structure and antigenicity analysis of N51 derived from the N-terminal heptad repeat domain in gp41 of HIV-1 CRF07_BC strain]Jiping Shao, Shibo Jiang, Shuwen LiuTrends in Immunology|April 8, 2023
High-throughput screening of mutations affecting SARS-CoV-2 spike functionsShuai Xia, Zezhong Liu, Shibo JiangBiotechnology Journal|June 12, 2024
Development of the IMP biosensor for rapid and stable analysis of IMP concentrations in fermentation brothShibo Jiang, Ying Lin, Suiping ZhengFrontiers in Immunology|January 13, 2018
Single-Domain Antibodies As Therapeutics against Human Viral DiseasesYanling Wu, Shibo Jiang, Tianlei YingCurrent Pharmaceutical Design|April 12, 2002
Peptide and non-peptide HIV fusion inhibitorsShibo Jiang, Qian Zhao, Asim K DebnathVaccines|September 2, 2020
Recent Advances in the Development of Virus-Like Particle-Based Flavivirus VaccinesNaru Zhang, Chaoqun Li, Shibo Jiang, et al.Expert Opinion on Therapeutic Patents|January 12, 2017
Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015)Wen Li, Lu Lu, Weihua Li, et al.Frontiers in Cellular and Infection Microbiology|September 12, 2022
Corrigendum: Advancement in the development of therapeutics against Zika virus infectionKangchen Li, Qianting Ji, Shibo Jiang, et al.Biochemical and Biophysical Research Communications|November 9, 2004
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entryYuxian He, Yusen Zhou, Pamela Siddiqui, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 23, 2007
The function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope protein-mediated cell fusionMiao-Ping Chien, Shibo Jiang, Ding-Kwo ChangPageof 50